. . . . . .

ADS Biotec, along with its parent company ADSTEC (Japan), is a global leader in the development, manufacture and sale of automated instruments and consumables for use in cytogenetic, pathology and research laboratories.

2022, 07/31- 08/03: Cancer Genomics Consortium (CGC)

  • 17/01/2022

July 31- August 3, 2022

Dear Colleagues,

It is my great privilege to invite you to the 13th Annual Meeting of the Cancer Genomics Consortium (CGC) scheduled for July 31 – August 3, 2022 in St. Louis, MO. The Scientific Program Committee is working hard to build an exciting agenda which will be updated regularly on our CGC website.

The CGC Annual Meeting is a unique gathering aimed at bringing the clinical genomics community together to create an environment of collaboration, education and networking. With the continuing and evolving partnerships between cytogeneticists molecular geneticists, pathologists, oncologists, and bioinformaticians, CGC is committed to playing an essential role in providing guidance on the best practice of genomic testing.

The meeting will include presentations from leading clinical genomics professionals, open discussions of best practices and guidelines, educational workshops, and ample opportunity to network with industry partners.

We are planning for a hybrid meeting with both in-person and online venues. Our hope is that a hybrid format will support the best aspects of in-person networking and engagement with speakers while also making the meeting more accessible and inclusive for a global audience.

Finally, we are excited to announce that abstract submission is now open. Please submit your latest cancer genomics research findings now.

We look forward to your participation in August 2022!

On behalf of the CGC 2022 Scientific Program Committee,

Obi Griffith, PhD
CGC 2022 Program Committee Chair